Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion

about

Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report.

P2860

Q55275094-39E27C5F-1668-44EB-9B59-799907F51468

P2860

Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion

Item

http://www.wikidata.org/entity/Q36186327

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Efficacy of single bevacizumab ...... branch retinal vein occlusion

@ast

Efficacy of single bevacizumab ...... branch retinal vein occlusion

@en

type

Item

label

Efficacy of single bevacizumab ...... branch retinal vein occlusion

@ast

Efficacy of single bevacizumab ...... branch retinal vein occlusion

@en

prefLabel

Efficacy of single bevacizumab ...... branch retinal vein occlusion

@ast

Efficacy of single bevacizumab ...... branch retinal vein occlusion

@en

P1476

Efficacy of single bevacizumab ...... branch retinal vein occlusion

@en

P2093

Astriviani Switania

http://www.w3.org/2001/XMLSchema#string

Siska Takarai

http://www.w3.org/2001/XMLSchema#string

Sutarya Enus

http://www.w3.org/2001/XMLSchema#string

P2860

Delayed absorption of macular edema accompanying serous retinal detachment after grid laser treatment in patients with branch retinal vein occlusion.

A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema

Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities

Comparative study of intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) in the treatment of neovascular age-related macular degeneration.

Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.

Retinal vein occlusion: beyond the acute event.

Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial.

Vascular endothelial growth factor a in intraocular vascular disease.

P304

2135-2140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OPTH.S116745

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Arief Kartasasmita

P577

2016-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27826179

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

Light Coagulation

P932

5096759

http://www.w3.org/2001/XMLSchema#string

Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion

about

P2860

P2860

Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932